Bicocca Open Archive

Logo unimib boa

Necchi, A., Giardiello, D., Mariani, L. (2017). Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer. EUROPEAN UROLOGY, 71(5), 840-841 [10.1016/j.eururo.2016.09.044].

Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer

Giardiello, D;
2017
Lettera in rivista
Antibodies, Monoclonal; Antineoplastic Agents, Immunological; B7-H1 Antigen; Data Interpretation, Statistical; Humans; Molecular Targeted Therapy; Probability; Research Design; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium
English
2017
71
5
840
841
none
Necchi, A., Giardiello, D., Mariani, L. (2017). Methodological Considerations for Early-phase Development of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer. EUROPEAN UROLOGY, 71(5), 840-841 [10.1016/j.eururo.2016.09.044].
01 - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/522402
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact